Resverlogix

Failed pivotal study? You can still have breakthrough therapy status — FDA signals to Resverlogix
Endpoints
Mon, 02/3/20 - 10:59 am
Resverlogix
breakthrough therapy
clinical trials
FDA
apabetalone
Resverlogix gets FDA input, redesigns kidney trial
BioPharma Dive
Fri, 02/24/17 - 11:35 am
Resverlogix
FDA
kidney dialysis
apabetalone
Resverlogix gets a $116M China drug development deal, stokes buyout buzz
Fierce Biotech
Wed, 04/29/15 - 08:16 am
Resverlogix
China
Resverlogix Places A BET On RVX-208
Seeking Alpha
Thu, 06/5/14 - 11:54 am
RVX-208
Resverlogix
BET-protein inhibitors
atherosclerosis
Resverlogix Plunges 93% After Drug Trial Fails
Bloomberg
Fri, 06/28/13 - 11:51 am
Resverlogix
RVX-208
A Successful Phase 2b Study Isn't As Meaningful As It Used To Be
Forbes
Wed, 09/5/12 - 12:41 pm
clinical trials
Resverlogix
RVX-208
Resverlogix Falls on Merck's `Huge Success' With Rival Cholesterol Drug
Bloomberg
Wed, 11/17/10 - 12:57 pm
Merck
Resverlogix
cholesterol
Pfizer Cholesterol Failures Cleared Path for Canadian Upstart
Bloomberg
Fri, 03/5/10 - 09:50 am
Pfizer
Resverlogix
cholesterol
Resverlogix: The Canadian Biotech Blockbuster
Minyanville
Mon, 10/5/09 - 10:38 am
Resverlogix
Canada
Alzheimer's disease